Risk stratification and prognosis of acute cardiac events in hospitalized adults with community-acquired pneumonia

Journal of Infection

Volumn 66, Issue 1, 2013, Pages 27-33

  Viasus, Diego ^a   Garcia Vidal, Carolina ^a   Manresa, Frederic ^a,b   Dorca, Jordi ^a,b   Gudiol, Francesc ^a,b   Carratalà, Jordi ^a,b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Acute cardiac events; Community acquired pneumonia; Prognosis; Risk factors

Indexed keywords

AGE; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DETERIORATION; FATALITY; FEMALE; HEART ARRHYTHMIA; HEART DISEASE; HEART INFARCTION; HOSPITAL PATIENT; HUMAN; HYPOALBUMINEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMONIA; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SEPTIC SHOCK; STREPTOCOCCUS PNEUMONIA; TACHYCARDIA;

AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PNEUMONIA; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SPAIN; TREATMENT OUTCOME;

EID: 84870747214     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2012.09.003     Document Type: Article

References (24)

1. Restrepo M.I., Anzueto A. Severe community-acquired pneumonia. Infect Dis Clin North Am 2009, 23:503-520.
2. File T.M., Marrie T.J. Burden of community-acquired pneumonia in North American adults. Postgrad Med 2010, 122:130-141.
3. Corrales-Medina V.F., Musher D.M., Wells G.A., Chirinos J.A., Chen L., Fine M.J. Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circulation 2012, 125:773-781.
4. Mandal P., Chalmers J.D., Choudhury G., Akram A.R., Hill A.T. Vascular complications are associated with poor outcome in community-acquired pneumonia. QJM 2011, 104:489-495.
5. Ramirez J., Aliberti S., Mirsaeidi M., Peyrani P., Filardo G., Amir A., et al. Acute myocardial infarction in hospitalized patients with community-acquired pneumonia. Clin Infect Dis 2008, 47:182-187.
6. Corrales-Medina V.F., Serpa J., Rueda A.M., Giordano T.P., Bozkurt B., Madjid M., et al. Acute bacterial pneumonia is associated with the occurrence of acute coronary syndromes. Medicine (Baltimore) 2009, 88:154-159.
7. Musher D.M., Rueda A.M., Kaka A.S., Mapara S.M. The association between pneumococcal pneumonia and acute cardiac events. Clin Infect Dis 2007, 45:158-165.
8. Singanayagam A., Singanayagam A., Elder D.H., Chalmers J.D. Is community-acquired pneumonia an independent risk factor for cardiovascular disease?. Eur Respir J 2012, 39:187-196.
9. Corrales-Medina V.F., Madjid M., Musher D.M. Role of acute infection in triggering acute coronary syndromes. Lancet Infect Dis 2010, 10:83-92.
10. McKee P.A., Castelli W.P., McNamara P.M., Kannel W.B. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971, 285:1441-1446.
11. Fine M.J., Auble T.E., Yealy D.M., Hanusa B.H., Weissfeld L.A., Singer D.E., et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997, 336:243-250.
12. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655.
13. Mandell L.A., Wunderink R.G., Anzueto A., Bartlett J.G., Campbell G.D., Dean N.C., et al. Infectious Disease Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007, 44(Suppl. 2):S27-S72.
14. Halm E.A., Fine M.J., Marrie T.J., Coley C.M., Kapoor W.N., Obrosky D.S., et al. Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. JAMA 1998, 279:1452-1457.
15. Antman E.M., Anbe D.T., Armstrong P.W., Bates E.R., Green L.A., Hand M., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction). J Am Coll Cardiol 2004, 44:E1-E211.
16. Menéndez R., Sahuquillo-Arce J.M., Reyes S., Martínez R., Polverino E., Cillóniz C., et al. Cytokine activation patterns and biomarkers are influenced by microorganisms in community-acquired pneumonia. Chest 2012, 141:1537-1545.
17. Antunes G., Evans S.A., Lordan J.L., Frew A.J. Systemic cytokine levels in community-acquired pneumonia and their association with disease severity. Eur Respir J 2002, 20:990-995.
18. Fernandez-Serrano S., Dorca J., Coromines M., Carratalà J., Gudiol F., Manresa F. Molecular inflammatory responses measured in blood of patients with severe community-acquired pneumonia. Clin Diagn Lab Immunol 2003, 10:813-820.
19. Filippatos G.S., Desai R.V., Ahmed M.I., Fonarow G.C., Love T.E., Aban I.B., et al. Hypoalbuminaemia and incident heart failure in older adults. Eur J Heart Fail 2011, 13:1078-1086.
20. Arquès S., Ambrosi P., Gélisse R., Luccioni R., Habib G. Hypoalbuminemia in elderly patients with acute diastolic heart failure. J Am Coll Cardiol 2003, 42:712-716.
21. Foley R.N., Parfrey P.S., Harnett J.D., Kent G.M., Murray D.C., Barre P.E. Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol 1996, 7:728-736.
22. Devereaux P.J., Yang H., Yusuf S., Guyatt G., Leslie K., Villar J.C., et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008, 371:1839-1847.
23. Dunkelgrun M., Boersma E., Schouten O., Koopman-van Gemert A.W., van Poorten F., Bax J.J., et al. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV). Ann Surg 2009, 249:921-926.
24. Alpert J.S., Thygesen K., Antman E., Bassand J.P. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000, 36:959-969.